Babulal, Ganesh M. http://orcid.org/0000-0001-7966-3509
Stout, Sarah H.
Williams, Monique M.
Rajasekar, Ganesh
Harmon, Annie
Vivoda, Jonathon
Zuelsdorff, Megan
Benzinger, Tammie L.S.
Morris, John C.
Ances, Beau
Roe, Catherine M.
Funding for this research was provided by:
National Institute on Aging (R03-AG055482, P01-AG03991)
National Institute on Aging (R01-AG056466, R01-AG043434, R01-AG43434-03S1, P50-AG05681, P01-AG026276, R01-AG057680)
Alzheimer's Association (AARFD-16-439140)
Article History
Received: 22 August 2019
Revised: 11 October 2019
Accepted: 14 October 2019
First Online: 4 November 2019
Compliance with Ethical Standards
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Washington University Human Research Protection Office [201706043]) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Dr. Babulal reports no disclosures or conflicts. Ms. Stout reports no disclosures. Dr. Williams reports no disclosures. Mr. Rajasekar reports no disclosures. Dr. Harmon reports no disclosures. Dr. Vivoda reports no disclosures. Dr. Zuelsdorff reports no disclosures. Dr. Benzinger is funded by NIH grants # P50AG005681; UF1AG032438; U01AG042791; 2P01AG003991; P01AG026276; R01AG043434; U54 MH091657; and the Barnes-Jewish Hospital Foundation. Dr. Benzinger reports no conflicts of interest. Dr. Morris and his family do not own stock or have equity interest (outside of mutual funds or other externally directed accounts) in any pharmaceutical or biotechnology company. Dr. Morris has participated or is currently participating in clinical trials of antidementia drugs sponsored by the following companies: Janssen Immunotherapy, Pfizer, Eli Lilly/Avid Radiopharmaceuticals, SNIFF (The Study of Nasal Insulin to Fight Forgetfullness) study, and A4 (The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease) trial. Dr. Morris has served as a consultant for Lilly USA, and Charles Dana Foundation. He receives research support from Eli Lilly/Avid Radiopharmaceuticals and is funded by NIH grants # P50AG005681; P01AG003991; P01AG026276 and UF1AG032438. Dr. Morris reports no conflicts of interest. Dr. Ances reports no disclosures. Dr. Roe reports no disclosures.